Everest Medicines Limited

HKEX:1952.HK

22.9 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q1
Operating Activities:
Net Income -210.426-210.426-211.806-211.806210.38210.38-334.021-334.021-312.806-312.806-191.554-191.554-2,517.317-2,517.317-927.49303.95999.123
Depreciation & Amortization 16.99716.99714.81414.8149.6929.69210.42110.4218.3878.3876.9936.9935.2545.2546.7043.1841.789
Deferred Income Tax 00-328.404-25.17234.529-35.29-59.780000000335.5580.1210.439
Stock Based Compensation 14.05814.05822.65222.65242.44842.44860.860.874.17674.17638.31438.31437.25937.2598.85333.8995.918
Change In Working Capital -41.309-41.30958.94458.944-46.246-46.246-3.748-3.748-9.522-9.522-10.29-10.29-6.008-6.008-31.93829.742-24.713
Accounts Receivables -24.517-24.5172.1952.195-2.28-2.28-0.303-0.303-0.025-0.025001.6881.688-2.967-0.409-1.015
Change In Inventory -3.978-3.9780.3250.325-4.879-4.879-0.717-0.717-0.224-0.2240000000
Change In Accounts Payables 00-239.0380142.08000000000000
Other Working Capital -12.814-12.81456.42556.425-39.088-39.088-2.729-2.729-9.274-9.274-10.29-10.29-7.696-7.696-10.17414.792-22.941
Other Non Cash Items 56.78456.784-105.303-105.303-536.437-536.4378.8318.83169.06269.062-37.728-37.7282,354.8282,354.828472.415-454.938-129.421
Operating Cash Flow -163.896-163.896-220.699-220.699-320.163-320.163-257.717-257.717-170.703-170.703-194.265-194.265-125.984-125.984-135.898-84.033-46.865
Investing Activities:
Investments In Property Plant And Equipment -22.9-22.9-35.768-35.768-107.552-107.552-70.406-70.406-48.069-48.069-6.907-6.907-2.951-2.951-422.068-51.4720
Acquisitions Net 00616.9990634.31600000000000-30.002
Purchases Of Investments 00-1,969.46100000000000000
Sales Maturities Of Investments 001,352.46200000000000000
Other Investing Activites -48.06-48.06482.977482.977-314.241-314.241-21.814-21.814-398.298-398.298-34.635-34.635-20.244-20.244-422.046-48.797-30.002
Investing Cash Flow -70.96-70.96447.209447.209-421.793-421.793-92.22-92.22-446.367-446.367-41.542-41.542-23.195-23.195-422.068-51.472-30.002
Financing Activities:
Debt Repayment 00-240.81400000000000-2,152.034-102.945-0.994
Common Stock Issued 0019.18704.224000000000000
Common Stock Repurchased 00000000-29.354-29.3540000000
Dividends Paid 00000000000000000
Other Financing Activities 109.189109.189-104.137-104.137-5.439-5.439-7.217-7.217-6.487-6.487-2.414-2.4141,691.4531,691.4532,152.034102.9450
Financing Cash Flow 109.189109.189-104.137-104.137-5.439-5.439-7.217-7.217-35.84-35.84-2.414-2.4141,691.4531,691.4532,152.034102.945-0.994
Other Information:
Effect Of Forex Changes On Cash -12.176-12.17631.60831.60814.37614.37615.54115.541-12.553-12.553-16.852-16.852-130.874-130.874-9.21-0.036-3.794
Net Change In Cash -137.843-137.843-992.359153.981-439.694-733.019-341.613-341.613-665.463-665.463-255.072-255.0721,411.41,411.41,584.858-32.596-81.655
Cash At End Of Period -137.843-137.843861.706153.9811,854.0651,223.8071,956.826-341.613-665.4633,305.5163,970.978-255.0721,411.43,069.7231,658.32373.465101.848